Key Metrics
5.3
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
29
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.9
5-Year SI
5-year SI
- N/A 2-year SI
- 0.88 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q2
Neurology
SJR
- Q2 Neurology
- Q2 Neurology (clinical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.21
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
2 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Multiple sclerosis
- Migraine
- Alzheimer's disease
- Nervous system
- Hunter syndrome
- Polyneuropathy
- Observational study
- Domain knowledge
- Health care
- Deep brain stimulation
- Amantadine
- Control subjects
- Dementia
- Alemtuzumab
- Parkinson's disease
- Dimethyl fumarate
- Interferon
- Treatment options
- Spinal muscular atrophy
- Emotion recognition
Journal Specifications
| Overview | |
| Publisher | SPRINGER LONDON LTD |
| Language | English |
| Frequency | Semi-annual |
| Article Processing Charges | EUR 5500 | USD 6850 | GBP 4700 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Semi-annual |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 6 |
| Article Processing Charges | EUR 5500 | USD 6850 | GBP 4700 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY-NC |
| OA statement | Visit website |
Planning to publish in Neurology and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Chinese Translation and Validation of the Center for Neurologic Study Lability Scale.
- 16 Apr 24
- Neurology and therapy
-
Full paper
Vascular Endothelial Growth Factor and Ischemic Stroke Risk: A Mendelian Randomization Study.
- 15 Apr 24
- Neurology and therapy
-
Full paper
Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study.
- 9 Apr 24
- Neurology and therapy
-
Full paper
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis.
- 8 Apr 24
- Neurology and therapy
-
Full paper
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.
- 6 Apr 24
- Neurology and therapy
-
Full paper
Donanemab in Japanese Patients with Early Alzheimer's Disease: Subpopulation Analysis of the TRAILBLAZER-ALZ 2 Randomized Trial.
- 6 Apr 24
- Neurology and therapy
Scite analysis
Powered by scite_
600 articles received 5.5k citations see all
- 236 Supporting
- 5,045 Mentioning
- 31 Contrasting
Editorial notices
- 0 Retractions
- 0 Withdrawals
- 14 Corrections
- 9 Errata
- 0 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
75%
4 to 6 months
21%
7 to 9 months
2%
Above 9 months
1%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Neurology and Therapy been actively publishing?
Neurology and Therapy has been in operation since 2012 till date.
What is the publishing frequency of Neurology and Therapy ?
Neurology and Therapy published with a Semi-annual frequency.
How many articles did Neurology and Therapy publish last years ?
In 2023, Neurology and Therapy published 137 articles.
What is the eISSN & pISSN for Neurology and Therapy ?
For Neurology and Therapy,eISSN is 2193-6536 and pISSN is2193-8253.
What is Citescore for Neurology and Therapy ?
Citescore for Neurology and Therapy is 5.3.
What is H index for Neurology and Therapy ?
H index for Neurology and Therapy is 29.
What is SNIP score for Neurology and Therapy ?
SNIP score for Neurology and Therapy is 1.21.
What is the SJR for Neurology and Therapy ?
SJR for Neurology and Therapy is Q2.
Who is the publisher of Neurology and Therapy ?
SPRINGER LONDON LTD is the publisher of Neurology and Therapy.